510(k) Report

510(k) · Cleared

Cleared

Synchron Systems G7 Amylase (AMY7) Reagent with Model (S) A71607

K091846510(k) TraditionalCleared Oct 16, 2009116-day reviewClass II21 CFR 862.1070

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Beckman Coulter, Inc. · JFJ Catalytic Methods, Amylase

Cleared on Oct 16, 2009 as substantially equivalent to K070064 (Thermo Fisher Scientific, 2007) after a 116-day review. Its family tree reaches back 1 generation to 2007.

Decided
Oct 16, 2009
Review
116 days
Class
Class II
Product code
JFJ
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K070064 (2007). No later device cites it as a predicate yet.

K070064 · Amylase Eps Reagent · Thermo Fisher Scientific · 2007200620082010
K070064 · Amylase Eps Reagent · Thermo Fisher Scientific · 20070
  1. Root · 1 generation backK070064 Amylase Eps ReagentThermo Fisher Scientific · 2007
  2. This deviceK091846 Synchron Systems G7 Amylase (AMY7) Reagent with Model (S) A71607Beckman Coulter, Inc. · 2009
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K070064Amylase Eps ReagentThermo Fisher Scientific2007—
0 (this device)K091846Synchron Systems G7 Amylase (AMY7) Reagent with Model (S) A71607Beckman Coulter, Inc.2009—
FIG. 1 — Lineage of K091846, 2007–2009Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JFJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JFJ device

  1. #1 K210633 Amylase2score 3.7 · 2 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K070064Amylase Eps Reagent
Summary page 1
…_ _ _ _ _ _ I _ _ _ _ _ I ~~Num ber SYNCHRON Systems G7 AyaeESRgnt Thermo Fisher K070064 Amylase (AMY7) Reagent myaeESRgnt Scientific, Inc. 5.0 Description: AMY7…
Thermo Fisher Scientific2007—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All JFJ devices

JFJ Catalytic Methods, Amylase: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · JFJ

1in 2022

2007: 12008: 12009: 12012: 12013: 12019: 22022: 1
2007high 2 (2019) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JFJ

Too few JFJ 510(k)s in any year since 2007 to give a median.

Recalls per year · JFJ

1in 2007

2007: 1
2007high 1 (2007) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JFJ

1in 2025

2010: 12011: 22012: 12018: 22020: 12022: 12024: 12025: 1
2007high 2 (2011) · low 0 (2007)2025

MAUDE reports naming product code JFJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—10
20081—00
20091—00
20100—01
20110—02
20121—01
20131—00
20140—00
20150—00
20160—00
20170—00
20180—02
20192—00
20200—01
20210—00
20221—01
20230—00
20240—01
20250—01
20260—0—

What is it indicated for?

AMY7 reagent, in conjunction with SYNCHRON® System(s) and UniCel® DxC System(s), is intended for the quantitative determination of total Amylase activity in human serum, plasma or urine.

Amylase measurements are used primarily in the diagnosis and treatment of pancreatitis.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K091846: Synchron Systems G7 Amylase (AMY7) Reagent with Model (S) A71607.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K091846

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026